Skip to main content

Animals production of vaccine and pharmaceuticals, hybridomas, monoclonal antibodies.


Animals in the Production of Vaccines and Pharmaceuticals – Hybridomas and Monoclonal antibodies

Introduction

Animals have played a crucial role in the production of vaccines and pharmaceutical products. They serve as biological systems for the synthesis of complex proteins, antibodies, hormones, enzymes, and vaccines. Animal-based production is especially important when post-translational modifications are required. Hybridoma technology and monoclonal antibodies represent major breakthroughs in medical biotechnology.

Animals in the Production of Vaccines
Role of Animals

Animals are used:
As hosts for propagation of pathogens
For testing vaccine safety and efficacy
For large-scale production of antigens
Types of Vaccines Produced Using Animals

Live attenuated vaccines
Example: Rabies vaccine (grown in chick embryo)

Inactivated (killed) vaccines

Example: Polio vaccine
Toxoid vaccines
Example: Tetanus, Diphtheria
Subunit vaccines
Antigenic parts isolated from pathogens
Common Animal Systems Used

Chick embryo
Mice
Rabbits
Horses
Monkeys
Examples
Rabies vaccine – chick embryo cell culture
Influenza vaccine – embryonated chicken eggs
Antisera – produced in horses

Animals in the Production of Pharmaceuticals


Animals are used to produce:
Hormones
Enzymes
Blood products
Antibodies
Examples
Product
Animal Source
Insulin (earlier)
Pig, Cow
Growth hormone
Animal pituitary
Antivenom
Horse
Blood clotting factors
Humanized animals
Antibodies
Mouse, Rabbit


Hybridoma Technology
Definition


Hybridoma technology is a method used to produce monoclonal antibodies by fusing antibody-producing B-lymphocytes with immortal myeloma cells.
Developed By
Georges KΓΆhler and CΓ©sar Milstein (1975)
Nobel Prize – 1984

Steps in Hybridoma Technology

1. Immunization of Animal

Mouse is injected with a specific antigen.
B-cells in spleen produce antibodies.

2. Isolation of Spleen Cells

Antibody-producing B-lymphocytes are collected.

3. Fusion with Myeloma Cells

B-cells fused with cancerous myeloma cells using polyethylene glycol (PEG).
Forms hybridomas.

4. Selection of Hybridomas

Grown in HAT medium.
Only hybrid cells survive.

5. Screening

Hybridomas producing desired antibody are identified.

6. Cloning

Selected hybridomas cloned to obtain identical cells.

7. Large-scale Production

Cultured in bioreactors or injected into mice (ascites method).


Monoclonal Antibodies (mAbs)


Definition
Monoclonal antibodies are identical antibodies produced by a single clone of hybridoma cells and are specific to a single antigenic determinant (epitope).
Characteristics of Monoclonal Antibodies
Highly specific
Uniform in structure
Reproducible
Large-scale production possible


Applications of Monoclonal Antibodies


1. Medical Applications

Cancer diagnosis and therapy
Autoimmune diseases
Organ transplant rejection control
Targeted drug delivery

2. Diagnostic Uses

ELISA
Pregnancy test kits
Detection of pathogens

3. Research Applications

Identification of cell surface markers
Protein purification

4. Pharmaceutical Uses

Therapeutic antibodies (e.g., Rituximab, Trastuzumab)

Advantages of Animal-based Production
Proper protein folding
Post-translational modification
High biological activity
Limitations
Ethical concerns
Risk of contamination
High production cost
Immune reactions (HAMA response)


Conclusion
Animals play an indispensable role in the production of vaccines and pharmaceuticals. Hybridoma technology revolutionized antibody production, leading to the development of monoclonal antibodies with wide applications in medicine, diagnostics, and research. Despite limitations, advances in biotechnology continue to improve safety and efficiency.

50 MCQ  

1. Hybridoma technology was developed by
a) Watson and Crick
b) Paul Ehrlich
c) KΓΆhler and Milstein
d) Jenner
✅ Answer: c
2. Hybridoma cells are formed by fusion of
a) T cells and B cells
b) B cells and myeloma cells
c) Myeloma and stem cells
d) Plasma cells and T cells
✅ Answer: b
3. Myeloma cells are
a) Normal B cells
b) Cancerous antibody-producing cells
c) Cancerous plasma cells
d) Stem cells
✅ Answer: c
4. PEG is used in hybridoma technology for
a) Cell culture
b) Screening
c) Cell fusion
d) Cloning
✅ Answer: c
5. HAT medium is used for
a) Fusion
b) Selection of hybridomas
c) Antibody purification
d) Immunization
✅ Answer: b
6. Monoclonal antibodies are
a) Different antibodies
b) Polyclonal antibodies
c) Identical antibodies
d) Mixed antibodies
✅ Answer: c
7. Source of B-lymphocytes in hybridoma technology
a) Liver
b) Bone marrow
c) Spleen
d) Thymus
✅ Answer: c
8. Animal commonly used in hybridoma technology
a) Rabbit
b) Mouse
c) Horse
d) Monkey
✅ Answer: b
9. Antigen is injected into which animal
a) Goat
b) Rat
c) Mouse
d) Horse
✅ Answer: c
10. Ascites method is used for
a) Vaccine production
b) Antibody purification
c) Large-scale mAb production
d) Screening
✅ Answer: c
11. Monoclonal antibodies recognize
a) Multiple epitopes
b) Single epitope
c) Whole antigen
d) Pathogen
✅ Answer: b
12. Polyclonal antibodies are produced by
a) Single B cell clone
b) Multiple B cell clones
c) Hybridoma cells
d) Myeloma cells
✅ Answer: b
13. ELISA uses
a) Enzymes
b) Antibodies
c) Antigens
d) All of the above
✅ Answer: d
14. Antivenom is produced in
a) Cow
b) Horse
c) Sheep
d) Mouse
✅ Answer: b
15. Influenza vaccine is produced using
a) Mouse cells
b) Bacterial cells
c) Chick embryo
d) Horse serum
✅ Answer: c
16. Rabies vaccine is produced in
a) Monkey kidney cells
b) Chick embryo
c) Human liver cells
d) Yeast cells
✅ Answer: b
17. Insulin was earlier extracted from
a) Sheep
b) Cow and pig
c) Mouse
d) Horse
✅ Answer: b
18. Toxoid vaccine example
a) Polio
b) Rabies
c) Tetanus
d) Measles
✅ Answer: c
19. Hybridomas are
a) Immortal cells
b) Short-lived cells
c) Dead cells
d) Stem cells
✅ Answer: a
20. Main advantage of monoclonal antibodies
a) Low specificity
b) High specificity
c) Low cost
d) Mixed response
✅ Answer: b
21. Myeloma cells lack ability to
a) Divide
b) Produce antibodies
c) Survive in culture
d) Fuse
✅ Answer: b
22. Nobel Prize for hybridoma technology was awarded in
a) 1975
b) 1980
c) 1984
d) 1990
✅ Answer: c
23. Pregnancy test kit works on
a) Antigen-antibody reaction
b) DNA hybridization
c) PCR
d) Cell fusion
✅ Answer: a
24. Monoclonal antibodies are used in
a) Cancer therapy
b) Diagnosis
c) Research
d) All of the above
✅ Answer: d
25. HAMA reaction occurs due to
a) Mouse antibodies in humans
b) Human antibodies in mice
c) Viral infection
d) Bacterial contamination
✅ Answer: a
26. Antibody-producing cells are
a) T lymphocytes
b) B lymphocytes
c) Macrophages
d) Neutrophils
✅ Answer: b
27. Which vaccine uses killed pathogen
a) Live vaccine
b) Inactivated vaccine
c) Subunit vaccine
d) Toxoid
✅ Answer: b
28. Monoclonal antibodies are uniform because they are produced from
a) Different cells
b) Same clone
c) Different antigens
d) Multiple species
✅ Answer: b
29. Cell fusion in hybridoma is chemical mediated by
a) Ethanol
b) PEG
c) Methanol
d) Acetone
✅ Answer: b
30. Animal used for antiserum production
a) Mouse
b) Horse
c) Rabbit
d) Monkey
✅ Answer: b
31. Diagnostic use of mAbs includes
a) Blood grouping
b) ELISA
c) Cancer markers
d) All
✅ Answer: d
32. Vaccine containing weakened pathogen
a) Killed
b) Toxoid
c) Live attenuated
d) Subunit
✅ Answer: c
33. Main limitation of animal-based pharmaceuticals
a) Ethical issues
b) High specificity
c) Easy availability
d) Low cost
✅ Answer: a
34. Hybridoma cells can be cultured
a) In vitro
b) In vivo
c) Both a and b
d) None
✅ Answer: c
35. Blood clotting factor VIII is used in
a) Diabetes
b) Hemophilia
c) Cancer
d) Malaria
✅ Answer: b
36. Subunit vaccines contain
a) Whole pathogen
b) Toxin
c) Antigenic part
d) DNA
✅ Answer: c
37. Primary host used in vaccine safety testing
a) Human
b) Animal
c) Plant
d) Microbe
✅ Answer: b
38. Hybridoma technology produces
a) Polyclonal antibodies
b) Monoclonal antibodies
c) Antigens
d) Vaccines
✅ Answer: b
39. Function of antibodies
a) Digestion
b) Immunity
c) Respiration
d) Excretion
✅ Answer: b
40. Which is NOT an application of monoclonal antibodies
a) Cancer therapy
b) Hormone production
c) Diagnosis
d) Research
✅ Answer: b
41. Antigen specificity of monoclonal antibodies is
a) Low
b) Moderate
c) High
d) Variable
✅ Answer: c
42. Ascitic fluid is rich in
a) Antigens
b) Antibodies
c) Hormones
d) Enzymes
✅ Answer: b
43. Vaccine against tetanus is
a) Live
b) Killed
c) Toxoid
d) Subunit
✅ Answer: c
44. Which animal is commonly used for polyclonal antibodies
a) Mouse
b) Rabbit
c) Horse
d) All
✅ Answer: d
45. Hybridoma cells are selected by
a) PEG
b) HAT medium
c) Antigen
d) Enzyme
✅ Answer: b
46. Monoclonal antibodies are used to identify
a) DNA
b) RNA
c) Cell surface markers
d) Lipids
✅ Answer: c
47. Production of vaccines requires
a) Animals
b) Microorganisms
c) Cell culture
d) All of the above
✅ Answer: d
48. First monoclonal antibody produced in
a) Human
b) Mouse
c) Rabbit
d) Horse
✅ Answer: b
49. Myeloma cells are
a) Mortal
b) Immortal
c) Dead
d) Differentiated
✅ Answer: b
50. Monoclonal antibodies are preferred because they are
a) Cheap
b) Non-specific
c) Highly specific
d) Unstable
✅ Answer: c



Comments

Popular Posts

Microbial Production of PharmaceuticalsSomatostatin, Humulin and Interferons

Microbial Production of Pharmaceuticals Somatostatin, Humulin and Interferons 1. Introduction Advances in recombinant DNA technology have enabled microorganisms to produce human therapeutic proteins safely, economically and in large quantities. Microbial systems such as Escherichia coli and yeast (Saccharomyces cerevisiae) are widely used for the production of pharmaceuticals that were earlier isolated from human or animal tissues. Important microbial-derived pharmaceuticals include somatostatin, human insulin (Humulin) and interferons. 2. Advantages of Microbial Production of Pharmaceuticals High yield and rapid production Cost-effective and scalable Free from animal pathogens Consistent product quality Easy genetic manipulation 3. General Steps in Microbial Production of Recombinant Pharmaceuticals Isolation of target gene Construction of recombinant DNA Insertion into suitable vector Transformation into host microorganism Expression of protein Downstream processing and purification ...

••CLASSIFICATION OF ALGAE - FRITSCH

      MODULE -1       PHYCOLOGY  CLASSIFICATION OF ALGAE - FRITSCH  ❖F.E. Fritsch (1935, 1945) in his book“The Structure and  Reproduction of the Algae”proposed a system of classification of  algae. He treated algae giving rank of division and divided it into 11  classes. His classification of algae is mainly based upon characters of  pigments, flagella and reserve food material.     Classification of Fritsch was based on the following criteria o Pigmentation. o Types of flagella  o Assimilatory products  o Thallus structure  o Method of reproduction          Fritsch divided algae into the following 11 classes  1. Chlorophyceae  2. Xanthophyceae  3. Chrysophyceae  4. Bacillariophyceae  5. Cryptophyceae  6. Dinophyceae  7. Chloromonadineae  8. Euglenineae    9. Phaeophyceae  10. Rhodophyceae  11. Myxophyce...

❃HPLC – High Performance Liquid Chromatography

HPLC – High Performance Liquid Chromatography ┏━━━━━ •❃°•°❀°•°❃•━━━━•━━━┓  1. Introduction High Performance Liquid Chromatography (HPLC) is an advanced analytical technique used for the separation, identification, and quantification of components present in a mixture. It is based on the differential distribution of analytes between a stationary phase and a liquid mobile phase under high pressure. HPLC is widely used in biochemistry, biotechnology, pharmaceuticals, food analysis, environmental studies, and clinical diagnostics. 2. Principle of HPLC The principle of HPLC is based on partition, adsorption, ion-exchange, or size-exclusion mechanisms, depending on the type of column used. A liquid mobile phase is pumped at high pressure through a column packed with fine stationary phase particles Sample components interact differently with the stationary phase Components with stronger interaction elute slower Components with weaker interaction elute faster Separated components are detec...

Intellectual Property Rights (IPR) – Detailed Notes

Intellectual Property Rights (IPR) – Detailed Notes 1. Introduction Intellectual Property Rights (IPR) are legal rights granted to creators and inventors over their creations or inventions. They protect innovation and creativity, providing the owner exclusive rights to use, sell, or license their creation. IPR encourages research, development, and economic growth by rewarding creativity. 2. Importance of IPR Protects inventions, designs, and creative work. Prevents unauthorized use, copying, or commercialization. Encourages innovation and research. Provides financial benefits to inventors through licensing or royalties. Supports economic growth and competitiveness. Safeguards traditional knowledge and biodiversity. 3. Types of Intellectual Property Rights A. Patents Definition: Exclusive right granted to an inventor for a new invention for a limited period (usually 20 years). Requirements: Novelty – must be new and not published. Inventive step – non-obvious to someone skilled in the f...

Exploitation of Somaclonal and Gametoclonal Variations for Plant Improvement

Exploitation of Somaclonal and Gametoclonal Variations for Plant Improvement  1. Introduction Plant tissue culture often induces genetic and epigenetic variations among regenerated plants. These variations, when stable and heritable, can be exploited as a source of novel traits for crop improvement. Somaclonal variation: Variation arising in plants regenerated from somatic cells cultured in vitro. Gametoclonal variation: Variation arising in plants regenerated from gametic cells (anther, pollen, ovule culture). Both provide additional genetic variability beyond conventional breeding. 2. Somaclonal Variation 2.1 Definition Somaclonal variation refers to genetic variation observed among plants regenerated from somatic tissue cultures, such as callus, suspension cultures, or explants. Term coined by Larkin and Scowcroft (1981). 2.2 Sources of Somaclonal Variation Chromosomal changes Aneuploidy Polyploidy Chromosome rearrangements Gene mutations Point mutations Insertions and deletions...

SCAR (Sequence Characterized Amplified Region) Markers

SCAR (Sequence Characterized Amplified Region) Markers   Introduction SCAR markers are PCR-based DNA markers derived from RAPD, AFLP, or other random markers. Developed by Paran and Michelmore in 1993 to convert dominant, less reproducible markers into specific, reproducible, co-dominant markers. SCAR markers are locus-specific, reproducible, and sequence-characterized, making them ideal for marker-assisted selection (MAS). Principle SCAR markers are designed based on known DNA sequences obtained from cloned RAPD/AFLP fragments. Specific primers (18–24 bp) are synthesized to amplify a single, defined locus. The PCR amplification of this region generates a distinct band, which is highly reproducible and can distinguish homozygotes from heterozygotes if designed as co-dominant. Key idea: Random marker (e.g., RAPD) → Cloning & sequencing → Design specific primers → PCR → SCAR marker Materials Required Genomic DNA from the organism Specific primers (18–24 bp) designed from sequence...

❥NORTHERN BLOTTING

NORTHERN BLOTTING – 30 MARK DETAILED NOTES  π“†ž❥ π“†ž❥ π“†ž❥ π“†ž❥ π“†ž❥ π“†ž ❥ π“†ž❥ π“†ž❥  Northern blotting is a molecular biology technique used to detect specific RNA molecules in a complex mixture. It provides information about gene expression, RNA size, and transcript abundance by hybridizing RNA with a labeled complementary DNA or RNA probe. πŸ“Œ Named by analogy to Southern blotting (DNA detection). 2. Principle The principle of Northern blotting is based on: Separation of RNA molecules by size using denaturing agarose gel electrophoresis Transfer (blotting) of separated RNA onto a nylon or nitrocellulose membrane Hybridization of membrane-bound RNA with a labeled complementary probe Detection of RNA–probe hybrids by autoradiography or chemiluminescence ✔ Only RNA sequences complementary to the probe will be detected. 3. Types of RNA Analyzed mRNA (most common) rRNA tRNA miRNA and siRNA (with modified protocols) 4. Requirements / Materials Total RNA or poly(A)+ RNA Denaturing agarose ...

𓆉 INDEX PAGE -NOTETHEPOINT43

INDEX PAGE   MAIN    CONTENT 1.   HSST BOTANY SYLLABUS, DETAILED NOTES, MCQ 2.  SET GENERAL PAPER SYLLABUS, DETAILED NOTES, 50MCQ 3.  SET BOTANY SYLLABUS, DETAILED NOTES, MCQ 4. MSC BOTANY THIRD SEMESTER SYLLABUS, NOTES (KERALA UNIVERSITY ) 5. MSC BOTANY THIRD SEMESTER QUESTION PAPER (KERALA UNIVERSITY ) 6. MSC BOTANY FOURTH SEMESTER SYLLABUS &NOTES (KERALA UNIVERSITY ) 7. FOURTH SEMESTER MSC BOTANY PREVIOUS QUESTION PAPER  (KERALA UNIVERSITY )

Fourth Semester M.Sc. Degree Examination, September 2019BotanySpecial Paper II - ElectiveBO 242 a: BIOTECHNOLOGY(2013 Admission onwards)

Reg. No.......  Name......... G-5263 Fourth Semester M.Sc. Degree Examination, September 2019 Botany Special Paper II - Elective BO 242 a: BIOTECHNOLOGY (2013 Admission onwards) Max. Marks: 75 1. Answer the following questions: 1. Humulin 2. YAC 3. Cybrids 4. Hybridomas 5. IPR 6. Gene therapy 7. C DNA library 8. AFLP 9. Hairy root culture 10. Somacional variation (10 x 1=10 Marks) II. Answer the following questions in not more than 50 words : 11. (a) What are immobilized enzymes? What is its advantage? OR (b) Write a short note on molecular farming. 12. (a) Give an account of bioprocess technology for the production of secondary metabolites. OR (b) What are bioreactors? How it operates? 13. (a) What are probiotics?. How do they work? OR (b) Discuss the methodology and application of western blotting. 14. (a) Briefly explain the application of protoplast culture OR (b) Write a short note on gene therapy 15. (a) What are reporter genes? Discuss its utility in transformation studies O...

Information retrieval from databases - search concepts, Tools for searching, homology searching, finding Domain and Functional site homologies

Information retrieval from databases - search concepts, Tools for searching, homology searching, finding Domain and Functional site homologies Information Retrieval from Databases 1. Introduction Information retrieval in bioinformatics refers to the process of extracting relevant biological data (DNA, RNA, protein sequences, structures, or functional information) from databases. Aim : Identify sequences, functions, or structural features for analysis, comparison, and annotation. Databases can be primary (raw sequence data) or secondary/derived (annotated, processed data). 2. Search Concepts in Biological Databases 2.1 Types of Searches Exact Match Search Returns results only if the query exactly matches database entries. Useful for known accession numbers or IDs. Pattern/Keyword Search Searches based on specific motifs, keywords, or annotations. Example: “kinase domain,” “signal peptide.” Similarity/Homology Search Detects sequences similar to the query based on sequence alignment. Use...